Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Clean Technology
Information Technology
Medical Device


About: LambdaVision is designing and developing an innovative, protein-based retinal implant that utilizes the light-activated protein, bacteriorhodopsin, to stimulate the retina of patients suffering from impaired vision or loss of sight due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP).


CI Representative:
Daniel Wagner
Managing Director, Investments